At the International Neuromodulation Society (INS) 15th world congress (21–26 May 2022; Barcelona, Spain), researchers from over 40 countries will present plenary lectures and more than 470 abstracts about neuromodulation therapy and research—as per an INS press release.
In the first in-person global meeting of its kind in three years, the multidisciplinary programme will draw clinicians, engineers, scientists, post-doctoral fellows, current students, and device manufacturers. The event will feature such topics as:
- Recent findings in management of challenging chronic pain conditions, such as painful peripheral neuropathy or cluster headache
- Peripheral nerve stimulation strategies
- Neuromodulation for COVID-19
- Cardiovascular applications
- Brain-computer interfaces and neurostimulation for motor recovery after spinal cord injury
- Bioelectronic medicine, vagus nerve stimulation of the autonomic nervous system, and the gut-brain axis
- Potential newer forms of neuromodulation involving novel targets or microwave stimulation
- Neurostimulation research addressing such areas as neuroprotection, memory loss, and treatment-resistant depression
- Deep brain stimulation developments
- Non-invasive brain stimulation studies
- Effects of neurostimulation treatments for chronic pain on opioid consumption
- Current and emerging neuromodulation treatments for epilepsy and movement disorders
- Big data and chronic pain
- Neuromodulation to address genitourinary problems, including pelvic pain
- Mechanisms of action in neuropathic pain
“The theme, ‘Neuromodulation: From Scientific Theory to Revolutionary Therapy’, reflects the scientific underpinnings and clinical application of neuromodulation therapies to reduce symptoms and restore function in chronic conditions,” said INS president Marc Russo.
The three-and-a-half-day scientific programme is supplemented by a number of preconferences and workshops. During the main conference, on 24 May, there will also be a workshop for nurses and allied health professionals.
Meanwhile, leading up to its 15th world congress, the INS bestowed recognition on two pioneers in the field, Robert Foreman and Bengt Linderoth, as Giants of Neuromodulation. Over their decades-long careers, they accumulated evidence regarding spinal cord stimulation for chronic pain, and its mechanism of action, respectively, according to the INS.
